- Home
- PRZO vs SONN Comparison
PRZO vs SONN Comparison
Compare PRZO & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- SONN
- Stock Information
- Founded
- PRZO 2014
- SONN N/A
- Country
- PRZO Israel
- SONN United States
- Employees
- PRZO N/A
- SONN N/A
- Industry
- PRZO
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- SONN Health Care
- Exchange
- PRZO Nasdaq
- SONN Nasdaq
- Market Cap
- PRZO 32.3M
- SONN 32.4M
- IPO Year
- PRZO 2023
- SONN N/A
- Fundamental
- Price
- PRZO $1.40
- SONN $5.03
- Analyst Decision
- PRZO
- SONN Strong Buy
- Analyst Count
- PRZO 0
- SONN 1
- Target Price
- PRZO N/A
- SONN $20.00
- AVG Volume (30 Days)
- PRZO 966.5K
- SONN 737.2K
- Earning Date
- PRZO 08-28-2025
- SONN 12-16-2025
- Dividend Yield
- PRZO N/A
- SONN N/A
- EPS Growth
- PRZO N/A
- SONN N/A
- EPS
- PRZO N/A
- SONN N/A
- Revenue
- PRZO $1,007,440.00
- SONN $1,000,000.00
- Revenue This Year
- PRZO N/A
- SONN $5,376.22
- Revenue Next Year
- PRZO N/A
- SONN N/A
- P/E Ratio
- PRZO N/A
- SONN N/A
- Revenue Growth
- PRZO 80.42
- SONN 1689.52
- 52 Week Low
- PRZO $0.53
- SONN $1.08
- 52 Week High
- PRZO $3.16
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- PRZO 49.38
- SONN 53.13
- Support Level
- PRZO $1.16
- SONN $4.05
- Resistance Level
- PRZO $1.31
- SONN $5.14
- Average True Range (ATR)
- PRZO 0.09
- SONN 0.90
- MACD
- PRZO 0.01
- SONN 0.11
- Stochastic Oscillator
- PRZO 71.79
- SONN 71.38
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.